Product Information
XIGDUO XR 2.5 MG-1,000 MG TAB is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $9.6020 per EA under NDC 00310622560. Its NADAC has been published 376 times since Apr 17, 2019.
Strength
2.5; 1000 mg/1; mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310622560
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205649On Market Since
10/29/2014
Pharmacological Classes
Price Statistics
The NADAC for XIGDUO XR 2.5 MG-1,000 MG TAB has been published 376 times since Apr 17, 2019, and over the history we have for it it has risen 21.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6020 per EA |
|---|---|
| All-time high | $9.6103 (Oct 15, 2025) |
| All-time low | $7.9172 (Apr 17, 2019) |
| 52-week high | $9.6103 |
| 52-week low | $9.5896 |
| Median price | $8.7699 |
| Average price | $8.8559 |
| Largest weekly change | +3.0% (Jan 12, 2022) |
| Weeks tracked | 376 |
| Tracking since | Apr 17, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the dapagliflozin and metformin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XIGDUO XR 2.5 MG-1,000 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for XIGDUO XR 2.5 MG-1,000 MG TAB, manufactured by AstraZeneca Pharmaceuticals LP, is $9.6020 per EA (NDC 00310622560), effective Jun 24, 2026.
How has the price of XIGDUO XR 2.5 MG-1,000 MG TAB changed over time?
Over the history we have for it, the NADAC for XIGDUO XR 2.5 MG-1,000 MG TAB has risen 21.3%. It has been tracked across 376 weekly CMS publications since Apr 17, 2019.
What are the highest and lowest recorded NADAC prices for XIGDUO XR 2.5 MG-1,000 MG TAB?
Since Apr 17, 2019, the NADAC for XIGDUO XR 2.5 MG-1,000 MG TAB has ranged from a low of $7.9172 (Apr 17, 2019) to a high of $9.6103 (Oct 15, 2025), with a median of $8.7699 per EA.
Are there cheaper alternatives to XIGDUO XR 2.5 MG-1,000 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XIGDUO XR 2.5 MG-1,000 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures XIGDUO XR 2.5 MG-1,000 MG TAB?
XIGDUO XR 2.5 MG-1,000 MG TAB (NDC 00310622560) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification